基因检测公司GeneDx Holdings（股票代码：WGS）周二盘中股价大涨5.43%，引起投资者广泛关注。这一显著涨幅主要得益于公司发布的第三季度业绩超出市场预期。
根据公司公告，GeneDx第三季度实现营业收入1.167亿美元，远超分析师预计的1.041亿美元。公司不仅在收入方面表现强劲，第三季度每股收益也超出了市场预期。这些积极的财务指标显示出公司业务增长势头良好，运营效率不断提高。
值得注意的是，GeneDx还上调了2025年全年收入预期，从此前的4亿至4.15亿美元提高到4.25亿至4.28亿美元。这一调整反映出管理层对公司未来发展前景的信心增强。目前，9位分析师中有8位给予该股"买入"或更高评级，预测目标价中值为125美元。截至上一交易日收盘，GeneDx股价年内累计涨幅已达70%，显示出投资者对公司长期增长潜力的看好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.